
Agenus (AGEN) shares have risen 68.4% in the past four weeks, and analysts' mean price target of $6.33 suggests a further 26.6% upside; however, price targets should be viewed with skepticism. Despite this caveat, analysts' upward revisions of Agenus's EPS estimates and a 52.4% increase in the Zacks Consensus Estimate indicate potential for near-term gains, supported by a Zacks Rank #2 (Buy) rating.
Agenus (AGEN) shares have demonstrated significant recent momentum, gaining 68.4% over the past four weeks to close at $5.00. While Wall Street analysts project a mean short-term price target of $6.33, implying a further 26.6% upside, this forecast is accompanied by a notable standard deviation of $2.08, with individual targets ranging from $4.00 (a 20% decline) to $8.00 (a 60% increase). The article advises caution regarding the reliability of price targets, suggesting they can be misleading. However, a more compelling indicator for AGEN is the strong positive trend in earnings estimate revisions. Specifically, three analysts have revised their earnings per share (EPS) estimates upward for the current year in the last 30 days, with no downward revisions, resulting in a substantial 52.4% increase in the Zacks Consensus Estimate. This positive revision trend, coupled with AGEN's Zacks Rank #2 (Buy) status and a high per-ticker sentiment score of 0.85, suggests a fundamentally supported potential for continued near-term stock appreciation, despite the variability in analyst price targets.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
moderately positive
Sentiment Score
0.40
Ticker Sentiment